Nemaura Medical Inc.

NMRDOTC Markets OTCPK·Healthcare

$0.00▲ +0.00 (+0.00%)

Market openData as of 12:57 PM ET · 15-min delay

Analyst ratingnone

Every calculator, already run for NMRD

What is it worth?

P/E calculatorHow does this multiple compare to peers and its own history?Run →DCF calculatorTen years of free cash flow, discounted back to today.Run →Reverse DCFSolves the price backwards for the growth it already requires.Run →EV / EBITDAThe price with debt added and cash netted off.-1.7x PEG ratioThe multiple divided by the growth meant to justify it.Run →Graham numberGraham's ceiling from earnings and book value.Run →P/S ratioFor companies whose earnings are not the point yet.Run →Intrinsic valueDCF, multiples and Graham run together as one range.Run →

Is it any good?

ROIC calculatorWhether a dollar invested earns more than it costs.Run →Altman Z-scoreFive balance-sheet ratios weighted into a distress score.-7.45 · distress Piotroski F-scoreNine pass-fail tests on profit, leverage and efficiency.1 of 8 Debt to equityHow much of the balance sheet is borrowed.-1.66 Interest coverageHow many times operating profit covers the interest bill.1x Profit marginGross, operating and net, each against the sector.0.0% net Free cash flowOperating cash after the capex needed to keep going.-$10M Rule of 40Revenue growth plus margin, the software health line.

What does it return & pay?

ROE calculatorProfit against the equity shareholders left in.Run →EPS growthEarnings per share compounded over the filings.Run →CAGR calculatorCompound rate on revenue, earnings, cash or price.-85% rev Dividend yieldWhat it pays, and whether free cash flow covers it.0.00%Net payout yieldDividends plus buybacks, less shares issued.Run →Owner earningsBuffett's version: cash a buyer could actually take out.-$9M

You have the numbers on NMRD. Get the argument.

A written report on which of these readings actually decide the outcome for Nemaura Medical Inc., what has to stay true for the price to work, and the specific thing that would break it. The first one is free.

Key market data

Market cap$4,035

P/E (TTM)—

Forward P/E-0.0x

Beta-112.69

EPS (TTM)$-0.39

Dividend yield—

Volume500

Avg volume1.1K

52-week range

$0.00$0.00

Ownership & short interest

Short % float0.3%

Shares out$40.35M

Insider Trading Activity for NMRD

Insider	Role	Type	Shares	Price	Value	Date	Filing

About Nemaura Medical Inc.

Nemaura Medical Inc., a medical technology company, manufactures continuous glucose monitoring system in the United States. It offers sugarBEAT, a non-invasive continuous glucose monitoring device for use by persons with Type I and Type II diabetes, as well as screen pre-diabetic patients. The company also offers proBEAT, a wellness guidance notes, that provide prompts and educate users on factors affecting blood sugar profiles, as well as conducts diabetes prevention and reversal programs. Nemaura Medical Inc. was founded in 2009 and is based in New York, New York.

HealthcareMedical Devices36 employeesUnited States

NMRD — frequently asked

Is NMRD a buy right now?

Wall Street's consensus rating on Nemaura Medical Inc. is none. Ratings are a starting point — run the DCF and check the financial-health readings above before deciding.

Compare Nemaura Medical Inc. against related stocks

Explore additional stock overview pages and jump directly into full report generation for each symbol.

Sector peers

Most-followed names in the same sector.

LLY stock overview UNH stock overview JNJ stock overview MRK stock overview ABBV stock overview PFE stock overview AMGN stock overview ISRG stock overview

Nearby tickers

Additional public equities from our tracked universe.

NMMN stock overview NMFC stock overview NMTR stock overview NLTX stock overview NNBR stock overview NLOK stock overview NNN stock overview

Market leaders

Large-cap symbols investors frequently compare.

AAPL stock overview MSFT stock overview NVDA stock overview AMZN stock overview GOOGL stock overview META stock overview TSLA stock overview JPM stock overview

Investor Guides For Nemaura Medical Inc.

Start with the evergreen guides that matter most for Healthcare, then move back into the ticker page when you want to pressure-test the framework on a live name.

Equity Research ChecklistsThe healthcare diligence checklist worth running before you size anything Earnings Question BanksThe healthcare earnings questions that matter after the headline beat Valuation PlaybooksWhat deserves the multiple in healthcare Red Flag WatchlistsThe healthcare red flags that quietly wreck the thesis

Generate your full NMRD research report

DCF model, five-year financials, moat assessment, a BUY/HOLD/SELL rating, and the risks that matter — on Nemaura Medical Inc., in minutes. 3 free reports included with every account — no credit card required.